Inogen reports preliminary Q4 2022 revenue within prior guidance range

Inogen Inc

2022-FY EPS reported -$3.67 revenue$377,241,000

Preliminary Q4 revenue $87.5M-$88.5M, YoY growth 14.5%-15.8%.
Full year 2022 revenue $376.7M-$377.7M, YoY growth 5.2%-5.5%.
FX negatively impacted Q4 revenue by ~$1.3M and FY by ~$5.3M.
Results within previous Q4 guidance of $87M-$92M; CEO cites headwinds but expects productivity improvement.
Company to announce full Q4/FY results on Feb 23, 2023.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Inogen Inc reported fourth quarter and full year ended December 31, 2022 results: revenue in the range of $87.5 million to $88.5 million. Guidance reaffirmed.

Period: fourth quarter and full year ended December 31, 2022
Revenue: in the range of $87.5 million to $88.5 million
Guidance: reaffirmed
Result: preliminary results

Exact text from the filing

for the fourth quarter and the full year ended December 31, 2022. The Company estimates preliminary, unaudited total revenue in the fourth quarter of 2022 to be in the range of $87.5 million to $88.5 million, representing year-over-year growth of 14.5% to 15.8%. Full year 2022 total preliminary, unaudited revenue is expected to be in the range of $376.7 million to

View on SEC.gov

Browse all earnings releases →

Inogen Inc filing history →

Source: SEC EDGAR

accession 0000950170-23-000566

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.